GK
Gurjala Kirupanandam
About Gurjala Kirupanandam
Data last updated:
Gurjala Kirupanandam is a Director at Latin Labs Private Limited (since 2012) and Director at Stcc Medicare Private Limited (since 2017). The companies operate in Pharma and Business Services. The 2 current companies with reported revenue have a combined latest revenue of ₹5.14 Cr; the largest is Latin Labs Private Limited at ₹5.00 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 16 May 2012 | 2012 | ₹5.00 Cr (FY 2024) | Active | |
| Director | 19 Jan 2017 | 2017 | ₹14.1 Lakh (FY 2022) | Active |
Board colleagues of Gurjala Kirupanandam
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Gurjala Kirupanandam
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Gurjala Kirupanandam
Gurjala Kirupanandam currently holds 2 directorships: Latin Labs Private Limited (Director, since 16 May 2012, revenue ₹5.00 Cr (FY 2024)); Stcc Medicare Private Limited (Director, since 19 Jan 2017, revenue ₹14.1 Lakh (FY 2022)).
Gurjala Kirupanandam was first appointed on 16 May 2012 as Director at Latin Labs Private Limited. The most recent appointment on record is 19 Jan 2017 at Stcc Medicare Private Limited.
The 2 current companies of Gurjala Kirupanandam that report revenue have a combined latest revenue of ₹5.14 Cr: Latin Labs Private Limited ₹5.00 Cr (FY 2024); Stcc Medicare Private Limited ₹14.1 Lakh (FY 2022).
The current boards of Gurjala Kirupanandam's companies include Anandha Krishnan Venkatraman (Latin Labs Private Limited), Anbarasan Puvimathi (Latin Labs Private Limited), Bhuvaneswari (Latin Labs Private Limited), Dhamodharan (Latin Labs Private Limited), Dhanasekar (Latin Labs Private Limited), Ganapathy Rajaraman (Latin Labs Private Limited), among others.